MARKET

HBIO

HBIO

Harvard Biosci
NASDAQ
0.4952
+0.0232
+4.92%
After Hours: 0.4853 -0.0099 -2.00% 17:45 02/06 EST
OPEN
0.4830
PREV CLOSE
0.4720
HIGH
0.5061
LOW
0.4723
VOLUME
176.87K
TURNOVER
--
52 WEEK HIGH
1.700
52 WEEK LOW
0.2813
MARKET CAP
22.15M
P/E (TTM)
-0.4058
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HBIO last week (0126-0130)?
Weekly Report · 5d ago
Harvard Bioscience files to sell 9.5M shares of common stock for holders
TipRanks · 01/30 22:05
Harvard Bioscience Trims Footprint To Run Leaner, Faster, And Cheaper
Benzinga · 01/30 11:49
Harvard Bioscience Announces Major Global Manufacturing Consolidation
TipRanks · 01/29 22:24
Harvard Biosciene to Close Massachusetts Manufacturing Plant
Dow Jones · 01/29 22:19
*Harvard Bioscience: Initiative Expected to Deliver Approximately $3M in Cost Savings in 2027 and $4M in Annual Cost Savings Beginning in 2028 While Improving Throughput and Execution >HBIO
Dow Jones · 01/29 21:51
*Harvard Bioscience: Streamlining Production Footprint and Improving Manufacturing Efficiency Through Phased Closure of Holliston, Mass., Plant >HBIO
Dow Jones · 01/29 21:51
*Harvard Bioscience: Will Close Manufacturing Facility in Holliston and Transition U.S. Production to Manufacturing Hub in Minneapolis >HBIO
Dow Jones · 01/29 21:51
More
About HBIO
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.

Webull offers Harvard Bioscience Inc stock information, including NASDAQ: HBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HBIO stock methods without spending real money on the virtual paper trading platform.